AN2 Therapeutics, Inc. (ANTX)

2.97 -0.08 (-2.62%) USD  |  NASDAQ  |  Apr 10, 16:00
3.00 +0.03 (+1.01%) After-Hours: 20:00
More

AN2 Therapeutics EPS LT Growth Estimates

EPS LT Growth Estimates Chart

View EPS LT Growth Estimates for ANTX.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View EPS LT Growth Estimates Chart
Start Trial

Historical Data

View Historical Data
Start Trial

EPS LT Growth Estimates Range, Past 5 Years

View EPS LT Growth Estimates Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

EPS LT Growth Estimates Benchmarks

View EPS LT Growth Estimates Benchmarks
Start Trial
Relmada Therapeutics, Inc. --
ACADIA Pharmaceuticals, Inc. Upgrade
Alnylam Pharmaceuticals, Inc. --
Savara, Inc. --
BioMarin Pharmaceutical, Inc. Upgrade